Table 2 Quantitative MRCP and mpMRI data per AILD cohort (AIH vs. ASC)—report Median and IQRs.
AIH (N = 35) | ASC (N = 14) | p | |
|---|---|---|---|
mpMRI | |||
cT1 | 780 ± 76.0 | 801.5 ± 71.7 | 0.41 |
PDFF | 3.8 ± 11.1 | 1.7 ± 0.9 | 0.54 |
Quantitative MRCP metrics | |||
Percentage of the ducts with median diameter ranging 1–3 mm | 87.5 (8.9) | 87.8 (8.3) | 0.92 |
Percentage of the ducts with median diameter ranging 3–5 mm | 11.5 ± 7.8 | 11.1 ± 7.9 | 0.89 |
Percentage of the ducts with median diameter ranging 5–7 mm | 0.0 | 0.3 ± 0.5 | < 0.001 |
Percentage points along the bile duct centreline with diameter < 1 mm | 0.2 ± 0.2 | 0.1 ± 0.1 | 0.43 |
Percentage points along the bile duct centreline with diameter ranging 1–3 mm | 82.9 ± 8.6 | 82.9 ± 9.5 | 0.99 |
Percentage points along the bile duct centreline with diameter ranging 3–5 mm | 15.6 ± 7.3 | 15.4 ± 8.4 | 0.95 |
Percentage points along the bile duct centreline with diameter ranging 7–9 mm | ± 0.2 | 0.3 ± 0.5 | 0.018 |
Percentage points along the bile duct centreline with diameter < 9 mm | 0.0 | ± 0.2 | 0.016 |
Total number of strictures | 3.3 ± 3.1 | 13.2 ± 15.7 | < 0.001 |
Sum of absolute severity of strictures | 4.3 ± 4.7 | 18.8 ± 23.9 | < 0.001 |
Sum of relative severity of strictures | 137.5 ± 130.7 | 551.2 ± 649.4 | < 0.001 |
Total number of dilatations | 6.5 ± 6.3 | 26.4 ± 33.3 | < 0.001 |
Total length of dilatations (mm) | 46.0 ± 44.5 | 149.2 ± 176.5 | 0.002 |
Maximum dilatation diameter | 5.1 ± 1.3 | 6.9 ± 2.2 | 0.001 |
Sum of relative severity of candidate dilatations | 442.5 ± 440.0 | 1633.2 ± 2166.6 | 0.002 |
Number of ducts with strictures | 2.9 ± 2.4 | 11.2 ± 12.4 | < 0.001 |
Number of ducts with dilatations | 5.6 ± 4.9 | 20.8 ± 24.1 | < 0.001 |
Number of ducts with strictures/dilatations | 6.9 ± 5.3 | 24.5 ± 26.0 | < 0.001 |
Total length of ducts with abnormalities (strictures and dilatations) (mm) | 72.5 ± 62.7 | 251.9 ± 285.9 | < 0.001 |
